Health Economic Aspects of Platelet Concentrates: Comparing Cost and Reimbursement of Pathogen Inactivated and Conventional Platelet Concentrates in a German Comprehensive Cancer Center

INTRODUCTION: Pathogen inactivation (PI) utilizing amotosalen and UVA light (INTERCEPT(®) Blood System) is a well-established method for the production of safer platelet concentrates (PCs). While many studies describe clinical and logistical benefits of PI, the implications and potential challenges...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonn, Jennifer, Baltin, Christoph T., Osterkamp, Viola, Scheid, Christof, Holtick, Udo, Irsch, Johannes, Kron, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664333/
https://www.ncbi.nlm.nih.gov/pubmed/37482056
http://dx.doi.org/10.1159/000531742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664333/
https://www.ncbi.nlm.nih.gov/pubmed/37482056
http://dx.doi.org/10.1159/000531742

Ejemplares similares